Human Breast Cancer HCC1937 Transfection Kit

Description

HCC1937 is a cell line derived from a human breast cancer patient with a family history of breast cancer. HCC1937 cells have a mutation in the BRCA1 gene, a tumor suppressor gene that is frequently mutated in hereditary breast and ovarian cancers. These cells can form tumors when introduced into immunodeficient mice and are sensitive to DNA-damaging agents like ionizing radiation and cisplatin chemotherapy drugs. HCC1937 cells display aggressive characteristics commonly found in breast cancer cells, including a high rate of proliferation, anchorage-independent growth, and the ability to invade neighboring tissues. HCC1937 cells are commonly employed in breast cancer research as a model system to investigate the genetic and molecular mechanisms involved in hereditary breast cancer, as well as to evaluate the safety and effectiveness of potential therapeutic agents for breast cancer. CD BioSciences produces nanoparticle-based transfection reagent kits that are specifically designed for human breast cancer cell, which have demonstrated reproducible and high-efficiency transfection outcomes.